Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln - Reuters
- Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln Reuters
- Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal CNBC
- Bristol Myers to buy Karuana for $14 billion The Boston Globe
- Bristol Myers buying schizophrenia drug developer Karuna for $14 billion Axios
- KRTX Stock Soars On Bristol Myers' $14 Billion Takeover Investor's Business Daily